Target intelligence / Profile preview

NAD+ biosynthetic and metabolizing enzymes

Molecular classification
Enzyme, Transferase, Hydrolase, Oxidoreductase
01

Overview

NAD+ biosynthetic and metabolizing enzymes represent a diverse group of proteins that regulate the levels and activity of nicotinamide adenine dinucleotide (NAD+), a fundamental coenzyme for cellular redox reactions and a key substrate for signaling pathways [1, 2]. This category encompasses biosynthetic enzymes such as nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in the NAD+ salvage pathway, and NAD+-consuming enzymes including poly(ADP-ribose) polymerases (PARPs), sirtuins (SIRTs), and CD38 [5, 6]. These enzymes are essential for maintaining energy metabolism, genomic stability through DNA repair, and epigenetic regulation [7, 9]. Dysregulation of this enzymatic network is a hallmark of several diseases; for instance, many cancers exhibit an addiction to NAMPT-mediated NAD+ synthesis to support rapid proliferation, while age-related decline in NAD+ is linked to neurodegeneration and metabolic disorders [8, 15, 16]. Therapeutic interventions targeting these enzymes include NAMPT inhibitors (e.g., FK866) for cancer treatment, PARP inhibitors (e.g., olaparib) for DNA repair-deficient tumors, and NAD+ precursors or sirtuin activators to combat aging and metabolic decline [4, 10, 11]. Overall, these enzymes serve as critical metabolic sensors that link the energy status of the cell to vital physiological responses.

Other names
NAD+ metabolic enzymesNAD+ metabolism enzymesNAD+ biosynthetic pathway enzymesNAD+ consuming enzymes
02

Mechanism of action

Drugs targeting these enzymes primarily act by modulating cellular NAD+ levels or the activity of NAD+-dependent signaling proteins. NAMPT inhibitors deplete NAD+ to induce metabolic collapse and apoptosis in cancer cells. PARP inhibitors block DNA repair, leading to synthetic lethality in BRCA-mutant cells. CD38 inhibitors prevent NAD+ degradation and modulate calcium signaling or immune responses. Conversely, NAD+ precursors and sirtuin activators aim to restore NAD+ levels to improve mitochondrial function and promote healthy aging.

03

Biological functions

Energy metabolismDNA repairSignal transductionGene expression regulationCalcium signalingApoptosisCell cycle
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseMetabolic diseaseInflammationAging
05

Safety considerations

RetinotoxicityHematological toxicityGastrointestinal distressFlushingImmunosuppression
06

Interacting drugs

FK866

9 more in the full profile.

07

Biomarkers

NAD+ levelsNAMPT expressionCD38 expressionPARP activityNMN levelsBRCA1/2 mutation status

Beyond the preview

Go deeper on NAD+ biosynthetic and metabolizing enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAD+ biosynthetic and metabolizing enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call